PhenomeX

Traded on the St. Petersburg Stock Exchange
PhenomeX is a leading Digital Cell Biology company focused on enabling and accelerating the rapid development and commercialization of biotherapeutics and other cell-based products. The Berkeley Lights Platform captures deep phenotypic, functional and genotypic information for thousands of single cells in parallel and can also deliver the live biology customers desire in the form of the best cells.
P/E
Net profit
P/B
Book value
P/FCF
FCF
Yield
Growth potential

PhenomeX balance sheet

Report period2018 2019 2020 2021 2022
End date of the reporting period
Capitalization, $
Capitalization, $
Enterprise Value
Book Value
Shareholders Book Value
Current liabilities
Noncurrent liabilities
Total liabilities
Debt
Cash and cash equivalents
Net debt
Assets
Total ordinary shares
Ordinary share price

PhenomeX cash flows

Report period2018 2019 2020 2021 2022
End date of the reporting period
Sales
Gross profit
Operation Income
Earnings
Shareholders earnings
EBITDA
Operation Cashflow
Capital expenditure
Free Cash Flow
EPS

PhenomeX multipliers

Report period2018 2019 2020 2021 2022
P/E
E/P
P/B
P/S
P/FCF
L/A
Debt-To-Equity
Net Debt/EBITDA
EV/EBITDA

PhenomeX profitability

Report period2018 2019 2020 2021 2022
ROA
ROE
ROS
Gross margin
EBITDA Margin
Operating margin
PhenomeX assets
PhenomeX cash flows

PhenomeX dividend policy

The company does not pay dividends
PhenomeX news
22.03.2023
Berkeley Lights completed its merger with IsoPlexis. IsoPlexis shareholders received 0.612 shares of Berkeley Lights stock for each share of their company. They now own 24.8% of the combined company. Berkeley Lights shareholders own 75.2%. The merged company changed its name to PhenomeX and its share ticker to CELL.
22.12.2022
Berkeley Lights has entered into a merger agreement with IsoPlexis. IsoPlexis shareholders will receive 0.612 shares of Berkeley Lights stock for each share of their company. Upon completion, they will own 24.8% of the combined company. Berkeley Lights shareholders will own 75.2%. Combined company will be called PhenomeX and will trade under the ticker symbo...
10.05.2022
Berkeley Lights reported a GAAP loss of $21.426 million for the 3 months of 2022, up 38.8% from $15.435 million in the prior year. Revenue increased 8.5% to $20.206 million from $18.628 million a year earlier.
24.02.2022
Berkeley Lights' GAAP loss for 2021 was $71.724 million, up 72.5% from $41.584 million the previous year. Revenue increased 32.8% to $85.388 million from $64.303 million a year earlier.
General information
Company namePhenomeX
SectorHealth Care / Pharmaceuticals, Biotechnology & Life Sciences / Biotechnology / Biotechnology
Business address5858 Horton Street Suite 320 EmeryVille, CA 94608 United States
Mailing address5858 Horton Street Suite 320 EmeryVille, CA 94608 United States
Websitephenomex.com
Information disclosurewww.sec.gov